Aesica

Newcastle Upon Tyne, United Kingdom Founded: 2004 • Age: 22 yrs Acquired By Pharmaron
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
Request Access

About Aesica

Aesica is a company based in Newcastle Upon Tyne (United Kingdom) founded in 2004 was acquired by Pharmaron in January 2023.. Aesica has completed 1 acquisition, including R5 Pharmaceuticals. Aesica operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Newcastle Upon Tyne, United Kingdom
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pharmaron Manufacturing Services (Uk) Ltd
  • Date of Incorporation 23 Jul, 2004
  • Jurisdiction CRAMLINGTON, NORTHUMBERLAND, ENGLAND
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    Pharmaron

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Pharmaron

    & 1 more

    (Jan 10, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Aesica
Headcount 1000-5000
Employee Profiles 222
Board Members and Advisors 5
Employee Profiles
People
Mohan Kumar.s
Senior Executive
People
Neil Jones
Chief Commercial Officer (cco)
People
Filipa Reis
Quality Control Project Manager
People
Enrico Pigoni
Analista Del Controllo Qualità

Unlock access to complete

Board Members and Advisors
people
Richard Ridinger
Chairman
people
Matthias Wittkowski
Board Member
people
Clare Bousfield
Board Member
people
Marc Funk
Board Member

Unlock access to complete

Funding Insights of Aesica

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aesica

Aesica has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Pharmaron and Consort Medical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Portfolio of products for airway management and drug delivery
Founded Year Domain Location
Drug discovery and development services for small molecules are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aesica

Aesica has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include R5 Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Develops formulations for clinical trials ranging from solid-dose capsules to liquids and injectables
2006
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Aesica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aesica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aesica

Aesica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Integrated CDMO services for biopharma R&D and manufacturing are offered.
domain founded_year HQ Location
APIs manufacturing and formulation services are provided in therapeutic segments.
domain founded_year HQ Location
APIs and enzymes are manufactured through fermentation by the CDMO.
domain founded_year HQ Location
APIs and finished products are developed and manufactured.
domain founded_year HQ Location
Generic biocatalytic solutions are provided for pharmaceutical applications.
domain founded_year HQ Location
APIs and peptides are developed and manufactured by Asymchem.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aesica

Morningside welcomes two senior executives to Board of Directors
Eastmidlandsbusinesslink5 years ago
QrxPharma, Aesica expand drug delivery technology
Biospectrumasia12 years ago

Frequently Asked Questions about Aesica

When was Aesica founded?

Aesica was founded in 2004.

Where is Aesica located?

Aesica is headquartered in Newcastle Upon Tyne, United Kingdom.

Who is the current CEO of Aesica?

Manja Boerman is the current CEO of Aesica.

What does Aesica do?

Aesica is a pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dose forms.It offers end-to-end pharmaceutical development and manufacturing solution that comprises of capabilities in formulation development for API and finished dose, manufacturing at all scales and packaging services.it also offers end-to-end capabilities in the design, industrialization and manufacture of medical delivery device. Recently, the company won young achiever of the year chemical industry award.

Who are the top competitors of Aesica?

Aesica's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

How many acquisitions has Aesica made?

Aesica has made 1 acquisition, including R5 Pharmaceuticals.

Who are Aesica's investors?

Aesica has 2 investors. Key investors include Pharmaron, and Consort Medical.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available